The idea of using the unique genetic profile of tumor cells relative to somatic cells to selectively kill cancer has been applied by various groups, such as in the case of the chemical-genetic interaction between BRCA1/2 and PARP inhibitors [2], [3]. The gene discussed is PARP1; the disease is cancer.